Are We Close to Completely Curing Cancers?

Alongside cardiovascular disease, cancer is one of the world's 2 leading causes of death. WHO data show that of every 6 people worldwide, 1 dies from cancer. For over 100 years, we have worked tirelessly to control this group of diseases. How close are more effective treatments?
Current common treatments include chemotherapy, radiotherapy, oncological surgery, for prostate or breast cancer, hormone therapy and, for the last 5 years, immunotherapy . Combination treatments, nonsurgical (minimally invasive) treatments and molecular treatments have also begun, creating more effective options with fewer side effects.
Below, we review new treatments we hope will soon enter practice.
Strengthening immunity
Immunotherapy attracts attention by strengthening existing immunity against foreign substances; in cancer, it activates immunity against cancer cells.
Cancer cells behave almost intelligently, using different ways to deceive immunity. Thus, stimulating only one aspect does not work for every cancer, and resistance can also develop.
In 2017, Nature Immunologypublished a study finding that macrophages , white cells normally consuming foreign substances and cell debris, could not affect certain aggressive cancer cells. Cancer cells used 2 signals to prevent cleanup. Blocking these two pathways restored white cells' anticancer action.
- Related topic: What is the tumor microenvironment, and why does it matter for treatment?
Therapeutic viruses and innovative vaccines
Virus-based treatments have begun producing effective results. In early 2018 in the United Kingdom, reoviruses were reprogrammed for use. According to researchers, this first showed that a therapeutic virus could cross the blood-brain barrier. This treatment is also a type of immunotherapy approach, GBM and is thought potentially usable to treat more patients with this aggressive brain cancer.
- Related topic: First FDA-approved therapeutic virus vaccine: Lmlygic for malignant melanoma
Another immunotherapy development involves dendritic vaccines . Dendritic cells play important immune roles. They are collected from the patient, coated with tumor-specific substances (antigens), activated to recognize cancer and returned to the body.
New Swiss research equipped these vaccines with artificial receptors recognizing small vesicles within circulating cancer cells.
Studies also suggest combining immunotherapy and chemotherapy, particularly chemotherapy first, may be effective. Remember combinations also mean more side effects.
- Related topic: FDA-approved dendritic cell cancer vaccine: Provenge for prostate cancer
The nanoparticle revolution
Nanoparticlesare specially developed to deliver drugs directly to tumors, as small as approximately one part in 100 thousand of a meter. Nanotechnology -produced nanoparticles appear effective at delivering drugs to tumor tissue with minimal harm to normal tissue.
Some are designed for hyperthermia (heat) treatment , aiming to shrink cancer cells. Nanoparticles developed in 2017 by Chinese and British scientists destroyed cancer cells without harming normal cells.
Nanoparticles offer different approaches, targeting drug-resistance-causing cancer stem cells . Drug delivery to tumors successfully destroyed breast and endometrial cancer cells.
Another type, nanoprobes , can detect micrometastases missed by conventional methods.
- Related topic: In 2017, 4 developments revolutionized cancer treatment
Tumor "starvation" strategies
Another strategy cuts cancer cells' nutrient supply, potentially eliminating aggressive resistant tumors.
In January 2018, 3 studies aimed at cutting this supply were published.
The first blocked uptake of an amino acid used for growth, glutamine. Breast, lung and colon cancers particularly need it.
The second targeted energy-producing enzymes in breast cancer, stopping cell growth.
Another study blocked vitamin B2 uptake to prevent energy production.
Cancer treatments and epigenetics
Epigeneticsrefers to gene-expression-related changes affecting whether biological characteristics appear.
These changes, including cancer, may be determined by epigenetic factors. Cancer cells contain thousands of genetic and epigenetic abnormalities supporting development and progression.
Recently, important mechanisms are being explored in metastasis, drug resistance and the tumor microenvironment.
- Related topic: Genes Need Education Too! Epigenetic Treatments in Cancer
What does all this mean?
Cancer research centers worldwide use technological advances to develop treatments. Each cancer type requires separate treatments, and cancer differs in every patient.
Immune- and genetic-based systems are gaining importance. We will soon see treatments targeting cancer's vulnerabilities.
Cancer must be treated through a multidisciplinary approach. Modern medicine can successfully manage it through many scientific fields.
- Related topic: The 10 Hallmarks of Cancer
Sources
Engagement of MHC class I by the inhibitory receptor LILRB1 suppresses macrophages and is a target of cancer immunotherapy.
Nature Immunologyvolume, November 2017.
2. Charlie Comins ve ark.
Reoviral Therapy for Cancer: Strategies for Improving Antitumor Efficacy Using Radio- and Chemotherapy.
Gene Therapy of Cancer (Third Edition), 2014.
3. Mario Leonardo Squadrito ve ark.
EVIR: chimeric receptors that enhance dendritic cell cross-dressing with tumor antigens.
Nature Methods, 2018.
4. Wei Zhang ve ark.
Novel Nanoparticles with Cr3+ Substituted Ferrite for Self-regulating Temperature Hyperthermia.
Nanoscale, 2017.
5. Michael L Schulte ve ark.
Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models.
Nature Medicine, 2018.
6. Andrea E Murmann ve ark.
Small interfering RNAs based on huntingtin trinucleotide repeats are highly toxic to cancer cells.
EMBO reports, 2018.
Was this article helpful?
Your feedback helps us improve our content.





Reader comments
Share your comment
Your name and comment are published only after administrator approval. Your email address is never shown to visitors.
Be the first to comment.